Tango Therapeutics, Inc. Quarterly Return On Equity in % from Q4 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Tango Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q2 2024.
  • Tango Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was -44.7 %, a 0.77% decline year-over-year.
  • Tango Therapeutics, Inc. annual Return On Equity for 2023 was -42 %, a 10.7% decline from 2022.
  • Tango Therapeutics, Inc. annual Return On Equity for 2022 was -37.9 %, a 33.9% decline from 2021.
  • Tango Therapeutics, Inc. annual Return On Equity for 2021 was -28.3 %, a 85.3% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -44.7 -0.34 -0.77% Apr 1, 2024 Jun 30, 2024
Q1 2024 -44.4 -2.01 -4.75% Jan 1, 2024 Mar 31, 2024
Q4 2023 -42 -4.06 -10.7% Oct 1, 2023 Dec 31, 2023
Q3 2023 -41.4 -8.7 -26.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 -44.4 -16.8 -60.8% Apr 1, 2023 Jun 30, 2023
Q1 2023 -42.3 -16.1 -61.1% Jan 1, 2023 Mar 31, 2023
Q4 2022 -37.9 -9.6 -33.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 -32.7 +8.65 +20.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 -27.6 +94.8 +77.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -26.3 +109 +80.6% Jan 1, 2022 Mar 31, 2022
Q4 2021 -28.3 +164 +85.3% Oct 1, 2021 Dec 31, 2021
Q3 2021 -41.4 Jul 1, 2021 Sep 30, 2021
Q2 2021 -122 Apr 1, 2021 Jun 30, 2021
Q1 2021 -136 Jan 1, 2021 Mar 31, 2021
Q4 2020 -192 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.